In a significant ruling at the pleading stage, the Delaware Court of Chancery has refused to dismiss fraud claims brought by Diem-II, LLC and Diem-III, LLC (the "Plaintiffs") against Maisonette Inc. (the "Company"), its directors, its Chief Financial Officer (CFO), and its largest stockholder, a private equity fund (the "Stockholder"). The Plaintiffs allege they were fraudulently induced to invest in the Series C and D financing rounds of the children’s fashion e-commerce startup. The court’s decision hinges on the interpretation of a waiver clause in the stock purchase agreements and the plausibility of fraud allegations at this early juncture of the litigation.
The core of the dispute revolves around financial statements provided by Maisonette to the Plaintiffs. The Plaintiffs claim that they were presented with unaudited financial statements that painted a rosier picture of the Company’s performance than reality. Crucially, they allege that these statements were inaccurate and that the Company and its fiduciaries knew this at the time of the investment. The subsequent revelation of restated financial statements, showing lower earnings, profits, and EBITDA than previously disclosed, forms the basis of the fraud claims.
The Court of Chancery, presided over by Vice Chancellor Bonnie David, found that the Plaintiffs had presented a sufficiently plausible case to proceed with their allegations. This includes claims of fraudulent inducement against the Company, its directors, and CFO; a conspiracy to commit fraud involving the Stockholder and its designee on the Company’s board; and unjust enrichment of all defendants.
A key factor in the court’s decision was the interpretation of a waiver clause within the stock purchase agreements. While the agreements contained language where the Plaintiffs waived certain claims, the court determined that this waiver may not have unambiguously extended to claims of fraud. This interpretation is critical, as it allows the Plaintiffs’ core allegations of deceit to move forward.
Background and Chronology of Events
Maisonette Inc., founded in 2016, operates as an e-commerce platform for children’s fashion. The company’s trajectory took a significant turn in mid-2021 when its financial position necessitated a capital infusion. By July 2021, the Board of Directors was actively discussing the Company’s cash reserves and strategizing for a Series C financing round, anticipated by the close of the year.
The Plaintiffs entered the picture in September 2021, when the Company’s President reached out to solicit their participation in this upcoming financing. As part of this outreach, the Plaintiffs were provided with a "Pitch Deck," a presentation that detailed both historical financial performance and future projections for Maisonette. This presentation served as the initial catalyst for the Plaintiffs’ interest in investing.
Following up on the Pitch Deck, the Company’s newly appointed CFO furnished the Plaintiffs in October 2021 with the Company’s unaudited financial statements for the entirety of 2020 and the first three quarters of 2021. These statements, alongside financial projections for the remainder of 2021, were collectively referred to as the "2021 Financial Statements."
Unbeknownst to the Plaintiffs, a critical Board meeting took place in November 2021, during the Plaintiffs’ due diligence process. At this meeting, the Board received a presentation, dubbed the "Board Deck," which included a slide titled "Assessment of Finance Capabilities" (the "Financing Slide"). This slide reportedly highlighted deficiencies and identified areas needing "improvements" in the Company’s financial information.
The Plaintiffs committed to an initial investment in December 2021, purchasing a convertible promissory note with a face value of $8 million. This note was governed by New York law and was designed to automatically convert into Series C preferred stock upon the successful conclusion of the Series C financing round.
In January 2022, the CFO provided the Plaintiffs with updated unaudited financial statements, termed the "Updated Financial Statements." Subsequently, in February 2022, the Plaintiffs finalized their Series C investment by executing a stock purchase agreement (the "Series C SPA"). This agreement converted their initial $8 million note investment into Series C Preferred Stock and facilitated an additional $2.4 million investment in the same class of stock. The Series C SPA included standard representations and warranties from the Company concerning its financial statements and, significantly, a waiver from the Plaintiffs of any claims "in respect of each of the Note Documents."
The narrative of financial discrepancies continued into 2024, when the Plaintiffs participated in Maisonette’s subsequent financing round, the Series D. This participation granted them the right to designate one member to the Company’s Board. It was only after securing board representation that the Plaintiffs learned of a significant development: in 2022, Maisonette had restated its financial statements (the "Restated Financial Statements"). These revised statements revealed considerably lower net revenue, gross profit, gross profit margin, and EBITDA figures than had been presented in the 2021 Financial Statements and the Updated Financial Statements provided to the Plaintiffs prior to their investments.
This discovery prompted the Plaintiffs to initiate legal action, asserting, among other claims, that they had been fraudulently induced to invest by misrepresentations embedded in the financial statements provided by the Company, its directors, and its CFO.
The Court’s Rationale: Key Holdings
The Delaware Court of Chancery’s decision to deny dismissal of most of the Plaintiffs’ claims rests on several critical points:
The Ambiguity of the Waiver Clause
A central tenet of the defendants’ motion to dismiss was the waiver provision within the Series C SPA. They argued that the Plaintiffs had relinquished their right to pursue any claims related to the Note Documents. However, the court found this argument to be insufficiently persuasive at the pleading stage.
Under Delaware law, waivers of fraud or unknown claims are enforceable only if they clearly and unambiguously demonstrate a voluntary and intentional relinquishment of such rights. The specific language in the Series C SPA stated that the Plaintiffs waived claims "in respect of" the Note. The court interpreted this language as primarily extinguishing the Company’s outstanding obligations under the Note post-conversion and waiving "present and past failures under the Note," including defaults.
Vice Chancellor David noted that while the clause released claims "in respect of" the Notes, such as defaults, "at least one reasonable reading" of the provision suggests that the parties did not waive the right to pursue "unknown claims for fraud." The court emphasized that if the intention had been to broadly release unknown fraud claims, the parties would have needed to do so explicitly. Citing precedent, the court highlighted that waivers encompassing fraud typically contain explicit language such as "known and unknown" claims or specifically mention "including fraud." The absence of such clear language in the Maisonette SPA left the door open for the Plaintiffs’ fraud claims.
Materiality of Earnings-Based Inaccuracies in a Startup Context
The defendants attempted to argue that discrepancies in earnings-based metrics were immaterial to an investment decision in a startup. They contended that investors in early-stage companies typically focus on "unit economics," such as the LTV/CAC ratio (Lifetime Value of a Customer divided by Cost to Acquire a Customer), rather than traditional profitability metrics like EBITDA, especially in the initial years when losses are common.
The court, however, found this argument to be unconvincing. It reasoned that the unit economics on which the Plaintiffs relied were themselves derived from the Company’s historical performance. Therefore, if the historical information underpinning these unit economics was inaccurate, it directly impacted the reliability of the metrics the defendants claimed were more important. Consequently, whether the allegedly inaccurate historical information was material to the Plaintiffs’ investment decision presented a factual question that could not be resolved at the pleading stage. The court indicated that the truth or falsity of these claims would need to be determined through further discovery and potentially a trial.
Scienter Allegations Against Directors and CFO
Establishing "scienter"—the intent to deceive, manipulate, or defraud—is a critical element of a fraud claim. The Plaintiffs alleged that the directors and CFO either knew about the inaccuracies in the financial statements or acted with reckless indifference to the truth.
For the directors, the Plaintiffs pointed to the "Financing Slide" from the Board Deck. This slide reportedly indicated that the Company’s financial reporting relied on QuickBooks, a system with "limited capabilities." It also stated that "data sources for reporting were directionally correct but not entirely accurate," that "private label accounting was non-existent," and that the Company had not yet undergone an audit. While the court acknowledged that an inference of scienter from this single slide might be "weak," particularly as the slide described reporting as "directionally correct" and the directors themselves had invested significant personal funds, the court was bound to draw all reasonable inferences in favor of the Plaintiffs at the pleading stage. Thus, it found it "reasonably conceivable (if only barely so)" that the directors disseminated the financial statements "knowing that the financial information therein was not entirely accurate."
Regarding the CFO, her defense was that she was a recent hire and it was unreasonable to expect her to conduct a full audit of historical financials so early in her tenure. She argued she merely transmitted statements authorized by the Board and suggested improvements, believing them to be "directionally correct." The court, however, focused on the allegation that the CFO, in her capacity as CFO, prepared and provided financial statements while aware of their inaccuracies. The court found that the allegations that the financial statements were "prepared by" the CFO and subsequently "reviewed, adopted and approved by" the directors were "sufficiently specific to ascribe the misleading statements in those documents to all of those parties." This indicates that the court viewed the CFO’s role as more than just a passive conduit of information.
Conspiracy Allegations Against the Stockholder
The Plaintiffs further alleged that the Stockholder, a significant private equity fund, engaged in a conspiracy with the Company’s fiduciaries to defraud them. The narrative presented was that the Stockholder, facing the Company’s "dire financial condition," sought to "bail out" its existing investments and preserve its influence by inducing the Plaintiffs to inject "substantial new money."
The Stockholder countered that the alleged facts did not support a reasonable inference of a "meeting of the minds" among co-conspirators. However, the court found several points compelling enough to allow the claim to proceed:
- Pre-Investment Discussions: Employees of the Stockholder participated in closed-door meetings with the Company to discuss fundraising weeks before the Plaintiffs received the 2021 Financial Statements.
- Company’s Touting of Stockholder: Maisonette explicitly highlighted the Stockholder’s participation in the Series C and D financing rounds to persuade the Plaintiffs to invest.
- Direct Negotiation: The Stockholder, through its designee on the Board (the "Designee"), directly negotiated the terms of the Series C financing with the Plaintiffs.
- Designee’s Oversight: The Designee, acting in a capacity that the court found could be interpreted as advancing the Stockholder’s interests, oversaw the Company’s fundraising efforts and approved key documents, including the Pitch Deck, Updated Financial Statements, and SPAs.
- Undisclosed Litigation: The Designee failed to disclose his involvement as a defendant in separate litigation related to another claim the Plaintiffs had against the Company concerning representations about the absence of pending lawsuits.
The court concluded that it could not determine at the pleading stage whether the Designee acted solely on behalf of Maisonette or "at the behest of" the Stockholder, suggesting a potential alignment of interests that could support a conspiracy claim.
Unjust Enrichment
Finally, the court found that the Plaintiffs had presented sufficient facts to infer that all defendants were unjustly enriched. The core allegation is that the Company induced the Plaintiffs’ investment through misstatements, thereby enriching itself at the Plaintiffs’ expense.
Beyond the Company’s direct enrichment, the court also found it reasonably inferable that the directors, the CFO, and the Stockholder benefited indirectly. While they may not have received the investment funds directly, the Plaintiffs’ investment allegedly "extended the runway" for the Company. This extension of time could have allowed for a turnaround in the Company’s financial position or provided an opportunity for these defendants to "offload their equity on some other, unsuspecting investor." This indirect benefit, stemming from the alleged fraudulent inducement, forms the basis for the unjust enrichment claim against all parties.
Implications and Broader Impact
The Delaware Court of Chancery’s decision in Diem-II, LLC and Diem-III, LLC v. Maisonette carries significant implications for investors and companies engaged in financing rounds, particularly in the startup ecosystem.
For Investors:
The ruling underscores the importance of meticulous due diligence and the careful scrutiny of contractual language, especially waiver clauses. While investors may agree to waive certain claims, the court’s emphasis on unambiguous language protecting against fraud signals that such waivers are not always an absolute shield for potential misconduct. Investors are reminded that even in agreements with broad waivers, claims of intentional misrepresentation may still be viable if the facts alleged are sufficiently compelling. The case also highlights that material misrepresentations, even concerning metrics like earnings in a startup context, can form the basis of fraud claims if they are relied upon by investors.
For Companies and Their Fiduciaries:
The decision serves as a stern reminder to companies, their boards, and their executives about the paramount importance of accurate financial reporting and transparent disclosure. Even at the pleading stage, allegations of knowingly providing inaccurate financial information can survive a motion to dismiss, leading to potentially costly and time-consuming litigation. The court’s willingness to infer scienter based on the totality of the circumstances, including internal assessments of financial reporting capabilities, suggests that companies cannot easily dismiss concerns about their financial data. The ruling also emphasizes the potential liability for fiduciaries, including directors and officers, who are expected to act with a duty of care and loyalty.
For Private Equity Funds and Large Stockholders:
The case demonstrates that large stockholders and private equity investors are not immune from allegations of conspiracy and unjust enrichment. If their actions, particularly through board designees, are perceived as directly influencing or benefiting from fraudulent schemes to raise capital, they can be drawn into litigation. The court’s focus on the actions of the Stockholder’s Designee and the potential for the Designee to act at the behest of the Stockholder rather than solely for the Company’s benefit is a crucial takeaway. This reinforces the need for such entities to ensure their representatives on company boards act with integrity and avoid any appearance of impropriety.
The Diem-II, LLC and Diem-III, LLC v. Maisonette decision sets a precedent that fraudulent inducement claims in investment scenarios will be taken seriously by Delaware courts, even when faced with contractual waivers. It reinforces the principle that material misrepresentations, when adequately pleaded, can lead to prolonged legal battles, compelling parties to confront the substance of their alleged misconduct rather than simply dismissing claims based on procedural defenses. The path ahead for Maisonette and its co-defendants will involve extensive discovery and a rigorous examination of the evidence to determine the veracity of the Plaintiffs’ allegations.
